Page last updated: 2024-09-03

imatinib mesylate and Thromboembolism, Venous

imatinib mesylate has been researched along with Thromboembolism, Venous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Breccia, M; Chistolini, A; Di Prima, A; Fiori, L; Scalzulli, E; Serrao, A	1

Other Studies

1 other study(ies) available for imatinib mesylate and Thromboembolism, Venous

Article	Year
Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors. Clinical drug investigation, 2020, Volume: 40, Issue:12 Topics: Administration, Oral; Adult; Aged; Aniline Compounds; Anticoagulants; Cohort Studies; Female; Hemorrhage; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nitriles; Protein Kinase Inhibitors; Pyrimidines; Quinolines; Retrospective Studies; Venous Thromboembolism	2020

Article

Year

Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors.

Clinical drug investigation, 2020, Volume: 40, Issue:12

Topics: Administration, Oral; Adult; Aged; Aniline Compounds; Anticoagulants; Cohort Studies; Female; Hemorrhage; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nitriles; Protein Kinase Inhibitors; Pyrimidines; Quinolines; Retrospective Studies; Venous Thromboembolism

2020